Abstract
Hepatitis B virus (HBV) infection is an important contributor to the global burden of disease. Globally, 296 million people are living with chronic HBV infection, including 6 million children younger than 5 years, and about 1·5 million people newly infected with HBV annually.1 Furthermore, cirrhosis and hepatocellular carcinoma resulting from chronic HBV infection cause about 820 000 deaths per year.1 In 2016, WHO adopted the Global Health Sector Strategy on viral hepatitis, which called for a reduction of HBV incidence by 90% and mortality by 65% by 2030.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
